These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2967890)

  • 1. Increased platelet aggregation and release reaction in myotonic dystrophy.
    Bornstein NM; Zahavi M; Korczyn AD; Zahavi J
    J Neurol Sci; 1988 Apr; 84(2-3):239-46. PubMed ID: 2967890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal platelet aggregation in myotonic dystrophy.
    Bolhuis PA; Goldhoorn BG; de Groot JG
    J Neurol Sci; 1982 Nov; 56(2-3):337-42. PubMed ID: 6294258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity of platelets to adrenaline in human myotonic dystrophy.
    Bousser MG; Conard J; Lecrubier C; Samama M
    Lancet; 1975 Aug; 2(7929):307-9. PubMed ID: 50512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet functions, alpha 2-adrenergic receptors and cytoplasmic free calcium are normal in the myotonic dystrophy of Steinert.
    Lanza F; Cazenave JP; Hemmendinger S; Stierlé A; Tranchant C; Warter JM
    J Neurol Sci; 1987 Jun; 79(1-2):13-22. PubMed ID: 3039064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation in myotonia.
    Schapira AH; Hutton RA
    J Neurol Sci; 1985 Dec; 71(2-3):351-7. PubMed ID: 2935596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Thromboxane B(2) Generation and β-Thromboglobulin Release from Activated Platelets in Myotonic Dystrophy.
    Zahavi M; Bornstein NM; Zahavi J; Korczyn AD
    Platelets; 1993; 4(1):45-8. PubMed ID: 21043853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
    Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
    Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
    Zahavi J; Zahavi M
    Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP and epinephrine-induced release of platelet fibrinogen.
    Kaplan KL; Dauzier MJ; Rose S
    Blood; 1981 Oct; 58(4):797-802. PubMed ID: 7272509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of enhanced platelet aggregation and platelet sensitivity in migraine patients.
    Lechner H; Ott E; Fazekas F; Pilger E
    Cephalalgia; 1985 May; 5 Suppl 2():89-91. PubMed ID: 3160475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nifedipine on platelet function.
    Takahara K; Kuroiwa A; Matsushima T; Nakashima Y; Takasugi M
    Am Heart J; 1985 Jan; 109(1):4-8. PubMed ID: 3155583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADP, adrenaline and serotonin stimulate inositol 1,4,5-trisphosphate production in human platelets.
    Vanags DM; Lloyd JV; Rodgers SE; Bochner F
    Eur J Pharmacol; 1998 Sep; 358(1):93-100. PubMed ID: 9809874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes.
    Malyszko J; Urano T; Knofler R; Taminato A; Yoshimi T; Takada Y; Takada A
    Thromb Res; 1994 Sep; 75(5):569-76. PubMed ID: 7992257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
    Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
    Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation and plasma levels of beta-thromboglobulin in diabetes mellitus.
    Yamada K; Mori K; Goto Y
    Tohoku J Exp Med; 1981 Dec; 135(4):423-9. PubMed ID: 6175049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.